Over the past 12 months, 4 insiders at Moderna, Inc. filed 6 open-market SEC Form 4 transactions on MRNA: 0 purchases worth $0 and 6 sales worth $13.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 15, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 15, 26 | Stephen HogePresident | SELL | 53.3K | $67.60 | $3.6M |
| May 21, 26 | Noubar Afeyan | SELL | 9.3K | $46.84 | $434K |
| Mar 2, 26 | Shannon Thyme KlingerChief Legal Officer | SELL | 13.9K | $52.29 | $726K |
| Feb 23, 26 | Stephen HogePresident | SELL | 160.0K | $48.84 | $7.8M |
| Dec 11, 25 | Noubar AfeyanDirector | SELL | 23.9K | $29.49 | $703K |
| Dec 9, 25 | Abbas HussainDirector | SELL | 504 | $27.60 | $14K |
| Jun 11, 25 | Abbas HussainDirector | SELL | 312 | $28.00 | $9K |
| Mar 3, 25 | Stephane BancelChief Executive Officer | BUY | 102.8K | $31.53 | $3.2M |
| Mar 3, 25 | Paul SaganDirector | BUY | 31.6K | $31.76 | $1.0M |
| Dec 9, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 529 | $44.68 | $24K |
| Dec 3, 24 | Stephen HogePresident | SELL | 314 | $43.30 | $14K |
| Dec 3, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 112 | $43.30 | $5K |
| Nov 29, 24 | Stephen HogePresident | SELL | 291 | $42.79 | $12K |
| Nov 29, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 1.4K | $42.79 | $61K |
| Nov 29, 24 | James M MockChief Financial Officer | SELL | 1.4K | $42.79 | $61K |
| Nov 11, 24 | Stephen HogePresident | SELL | 277 | $46.10 | $13K |
| Oct 7, 24 | James M MockChief Financial Officer | SELL | 715 | $60.12 | $43K |
| Sep 9, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 551 | $73.57 | $41K |
| Sep 3, 24 | Stephen HogePresident | SELL | 318 | $76.99 | $24K |
| Sep 3, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 114 | $76.99 | $9K |
| Aug 29, 24 | Stephen HogePresident | SELL | 300 | $78.03 | $23K |
| Aug 29, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 162 | $78.03 | $13K |
| Aug 29, 24 | James M MockChief Financial Officer | SELL | 162 | $78.03 | $13K |
| Aug 28, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 1.3K | $79.39 | $105K |
| Aug 28, 24 | James M MockChief Financial Officer | SELL | 1.3K | $79.39 | $105K |
| Aug 12, 24 | Stephen HogePresident | SELL | 254 | $84.10 | $21K |
| Jul 31, 24 | Noubar AfeyanDirector | SELL | 5.7K | $121.62 | $679K |
| Jul 24, 24 | Noubar AfeyanDirector | SELL | 6.8K | $119.01 | $808K |
| Jul 17, 24 | Noubar AfeyanDirector | SELL | 6.7K | $124.61 | $829K |
| Jul 15, 24 | Stephen HogePresident | SELL | 15.0K | $121.12 | $1.8M |
| Jul 10, 24 | Noubar AfeyanDirector | SELL | 6.1K | $119.95 | $710K |
| Jul 8, 24 | James M MockChief Financial Officer | SELL | 689 | $118.24 | $81K |
| Jun 26, 24 | Noubar AfeyanDirector | SELL | 2.7K | $134.05 | $354K |
| Jun 18, 24 | Noubar AfeyanDirector | SELL | 6.8K | $136.92 | $917K |
| Jun 17, 24 | Stephen HogePresident | SELL | 15.0K | $138.16 | $2.1M |
| Jun 12, 24 | Noubar AfeyanDirector | SELL | 6.4K | $150.24 | $944K |
| Jun 11, 24 | Noubar AfeyanDirector | SELL | 163.6K | $149.40 | $24.3M |
| Jun 10, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 5.2K | $148.09 | $767K |
| Jun 5, 24 | Noubar AfeyanDirector | SELL | 3.9K | $154.86 | $592K |
| Jun 3, 24 | Stephen HogePresident | SELL | 339 | $140.72 | $48K |
| Jun 3, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 122 | $140.72 | $17K |
| Jun 3, 24 | James M MockChief Financial Officer | SELL | 691 | $140.72 | $97K |
| May 29, 24 | Noubar AfeyanDirector | SELL | 5.6K | $148.06 | $815K |
| May 29, 24 | Stephen HogePresident | SELL | 341 | $144.50 | $49K |
| May 29, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 183 | $144.50 | $26K |
| May 29, 24 | James M MockChief Financial Officer | SELL | 183 | $144.50 | $26K |
| May 28, 24 | Shannon Thyme KlingerChief Legal Officer | SELL | 1.3K | $162.47 | $211K |
| May 28, 24 | James M MockChief Financial Officer | SELL | 648 | $162.47 | $105K |
| May 22, 24 | Noubar AfeyanDirector | SELL | 2.2K | $164.67 | $362K |
| May 15, 24 | Noubar AfeyanDirector | SELL | 5.7K | $129.15 | $735K |
Over the past 12 months, insiders at Moderna, Inc. filed 0 open-market purchases worth $0 and 6 sales worth $13.3M on MRNA, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 15, 26.
The largest recent open-market MRNA insider purchase in our data was $3.2M by Stephane Bancel, Chief Executive Officer, filed on Mar 3, 25.
4 different insiders at Moderna, Inc. filed open-market SEC Form 4 transactions on MRNA over the last 12 months.
InsiderTape plots every MRNA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Moderna, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →